BioMedEcon Logo
PO Box 129 Moss Beach, CA 94038 | Phone: 650.563.9475
About UsCore Scientific OfferingsOur WorkPublications And PresentationsMedia CenterContact Us
  • A Leading Provider Of Health Economics and Outcomes Research
  • Browse Our Latest News
  • Comparative Effectiveness Research, Competitive Product Analyses And Much More
BIOMEDECON EVENTS
March 18-22, 2011
American Academy of Allergy Asthma & Immunology, San Francisco, CA. More Info

PUBLICATIONS
In Press
"Patients with obsessive-compulsive disorder vs depression have comparable healthcare costs: A retrospective claims analysis of Florida Medicaid enrollee". More Info

Recently Published
"The health economics of allergy immunotherapy."
More Info


UPCOMING PRESENTATIONS
Nov. 3-8, 2011 | Boston, MA
"Is subcutaneous immunotherapy cost effective?"  Presented at the 2011 Annual Meeting of the American College of Allergy, Asthma, and Immunotherapy. More Info >

Dec. 4-8, 2011 | Cancun, Mexico
  • "Cost effectiveness and compliance of specific immunotherapy." Presentation scheduled at the 2011 World Allergy Congress.
  • "Inner-city asthma: Barriers to access to care and implications for underserved populations." Presented at the 2011 World Allergy Congress.
    More Info >
Mar. 31, 2012 | Toronto Canada
Lecture to be presented at the 2012 Allergy Update.


THANK YOU FOR VISITING BIOMEDECON
BioMedEcon is a leading provider of health economics and outcomes research for the pharmaceutical, biotechnology, drug delivery, and medical device industries. BioMedEcon applies scientifically rigorous, customized, and solution-oriented approaches to demonstrate the clinical and economic value of our clients’ products.

BioMedEcon strongly believes that product value must be demonstrated throughout the product’s life cycle and across an ever-changing competitive and payer landscape. Our typical client engagements are therefore long term. We work collaboratively with our clients and key clinical and payer opinion leaders to identify, demonstrate, and present product value that optimizes coverage and reimbursement.


BIOMEDECON NEWS
BioMedEcon receivest jointly-funded grant from the American Association of Allergy, Asthma, and Immunotherapy (AAAAI) and the American College of Allergy, Asthma, and Immunology (ACAAI) to examine the comparative effectiveness of allergen-specific immunotherapy versus symptomatic drug treatment among adults with allergic rhinitis. More Info
 
About Us | Core Scientific Offerings | Our Work | Publications & Presentations | Media Center | Contact Us
© 2009 BioMedEcon